Zobrazeno 1 - 10
of 229
pro vyhledávání: '"P, Font Ugalde"'
Autor:
Desirée Ruiz-Vilchez, Lourdes Ladehesa-Pineda, María Ángeles Puche-Larrubia, María Carmen Ábalos-Aguilera, Pilar Font-Ugalde, Alejandro Escudero-Contreras, Eduardo Collantes-Estévez, Clementina López-Medina
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 16 (2024)
Background: Few studies have been conducted to investigate the socioeconomic profiles of patients with ankylosing spondylitis (AS) and their associations with disease severity and disability. Objectives: The objectives of this study were to identify
Externí odkaz:
https://doaj.org/article/9578d5fcc9e24450985355e48d3d0ed9
Autor:
Clementina López-Medina, M. Ángeles Puche-Larrubia, Raquel Granados, Lourdes Ladehesa-Pineda, Desirée Ruiz-Vilchez, M. Carmen Ábalos-Aguilera, Pilar Font-Ugalde, Eduardo Collantes-Estévez
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-9 (2023)
Abstract Background Enthesitis represents one of the most important peripheral musculoskeletal manifestations in patients with axial spondyloarthritis (axSpA). However, studies specifically evaluating Achilles tendon enthesitis and its impact over ti
Externí odkaz:
https://doaj.org/article/20e2298d59bf4d9bb8f91ab285e233c2
Autor:
Jordi Gratacós, Clementina López-Medina, Janitzia Vázquez-Mellado, Eduardo Collantes-Estevez, Alejandro Escudero-Contreras, Xavier Juanola, Pilar Font-Ugalde, María Ángeles Puche-Larrubia, Lourdes Ladehesa-Pineda
Publikováno v:
RMD Open, Vol 9, Iss 3 (2023)
Objective To describe and analyse the initial symptoms attributable to patients with spondyloarthritis (SpA) and their association with HLA-B27 status.Methods This was an observational, cross-sectional and multicentre study with patients who fulfille
Externí odkaz:
https://doaj.org/article/85921cbeb4c44521850d6724aab214d1
Autor:
Alba Erra, Clementina López-Medina, Helena Marzo-Ortega, Eduardo Collantes, Xavier Juanola, Xabier Michelena, Pilar Font-Ugalde
Publikováno v:
RMD Open, Vol 8, Iss 2 (2022)
Aims To explore the clinical and radiographical characteristics of axial psoriatic arthritis (PsA) and to compare it with ankylosing spondylitis (AS) with psoriasis.Methods Cross-sectional study from the national multicentre registry REGISPONSER wher
Externí odkaz:
https://doaj.org/article/39293459836341408da127a94f496c8b
Autor:
Ignacio Gómez-Garcia, Teresa García-Puga, Pilar Font-Ugalde, Maria Angeles Puche-Larrubia, Nuria Barbarroja, Patricia Ruiz-Limón, Alejandro Escudero-Contreras, Eduardo Collantes-Estévez, Clementina López-Medina
Publikováno v:
Therapeutic Advances in Musculoskeletal Disease, Vol 14 (2022)
Background: The relationship of psoriasis and spondyloarthritis (SpA) is well-known, and the age of appearance of different manifestations has been described as a determinant of SpA phenotype. However, differences between Spa with psoriasis and psori
Externí odkaz:
https://doaj.org/article/ffbc6e78508c4bc3a253adbc2b38d4f7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Patricia Ruiz-Limon, Maria Lourdes Ladehesa-Pineda, Maria del Carmen Castro-Villegas, Maria del Carmen Abalos-Aguilera, Clementina Lopez-Medina, Chary Lopez-Pedrera, Nuria Barbarroja, Daniel Espejo-Peralbo, Jose Antonio Gonzalez-Reyes, Jose Manuel Villalba, Carlos Perez-Sanchez, Alejandro Escudero-Contreras, Eduardo Collantes-Estevez, Pilar Font-Ugalde, Yolanda Jimenez-Gomez
Publikováno v:
Journal of Biomedical Science, Vol 27, Iss 1, Pp 1-16 (2020)
Abstract Background Radiographic axial spondyloarthritis (r-axSpA) is a chronic inflammatory form of arthritis in which tumor necrosis factor (TNF)-α, a potent inducer of inflammatory response and a key regulator of innate immunity and of Th1 immune
Externí odkaz:
https://doaj.org/article/9782f061728d4a7c8e14044f31a56183
Autor:
Ricardo Ruiz-Villaverde, Lourdes Rodriguez-Fernandez-Freire, Amalia Pérez-Gil, Pilar Font-Ugalde, Manuel Galán-Gutiérrez
Publikováno v:
Life, Vol 12, Iss 11, p 1883 (2022)
Introduction. Risankizumab is a humanized monoclonal antibody of the immunoglobulin G1 (IgG1) type that binds selectively, and with high affinity, to the p19 subunit of interleukin-23 (IL-23), resulting in the inhibition of inflammation and clinical
Externí odkaz:
https://doaj.org/article/1a9fd6d5f9224841aa9efe41d2646a74